These data suggest that KGF may be effective in the treatment of vaginal disorders also in patients undergoing cancer chemotherapy with tamoxifen for the treatment of oestrogen-sensitive tumours, which implies the ineffectiveness of oestrogen treatment. This evidence concerns the gene FGF7 and vaginal disorder.